Getting quick access to PEP is important because the course must be started within 72 hours of a potential exposure to HIV to be effective. That's the gap the directory aims to fill.

Activists urge India to waive clinical trial requirements for lenacapavir, as patent barriers threaten access to the vital ...

But the rollout is now being wielded as a political tool. What that “America First” slogan actually means for global health is starting to come into focus. Just days ago, the State Department ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

Students can schedule appointments via MySHR to consult with a provider and receive the recently FDA-approved twice-per-year ...

South Africa takes the lead in HIV prevention with a groundbreaking twice-a-year injection being added to the Essential Medicines List.

It's a Sin writer Russell T Davies has warned "the fight is not over" when it comes to eradicating HIV. He said ...

India has long been recognised as a global hub for affordable generic medicines. It provides a full year of antiretroviral ...

Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global health officials call a game-changer. The drug developed by Gilead ...

Director Provincial AIDS Control Program says illegal clinics, infected needles remain biggest causes of infections ...